Literature DB >> 16796383

Computational methods in drug design: modeling G protein-coupled receptor monomers, dimers, and oligomers.

Patricia H Reggio1.   

Abstract

G protein-coupled receptors (GPCRs) are membrane proteins that serve as very important links through which cellular signal transduction mechanisms are activated. Many vital physiological events such as sensory perception, immune defense, cell communication, chemotaxis, and neurotransmission are mediated by GPCRs. Not surprisingly, GPCRs are major targets for drug development today. Most modeling studies in the GPCR field have focused upon the creation of a model of a single GPCR (ie, a GPCR monomer) based upon the crystal structure of the Class A GPCR, rhodopsin. However, the emerging concept of GPCR dimerization has challenged our notions of the monomeric GPCR as functional unit. Recent work has shown not only that many GPCRs exist as homo- and heterodimers but also that GPCR oligomeric assembly may have important functional roles. This review focuses first on methodology for the creation of monomeric GPCR models. Special emphasis is given to the identification of localized regions where the structure of a GPCR may diverge from that of bovine rhodopsin. The review then focuses on GPCR dimers and oligomers and the bioinformatics methods available for identifying homo- and heterodimer interfaces.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16796383      PMCID: PMC3231557          DOI: 10.1007/bf02854903

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  116 in total

1.  Activation of the cannabinoid CB1 receptor may involve a W6 48/F3 36 rotamer toggle switch.

Authors:  R Singh; D P Hurst; J Barnett-Norris; D L Lynch; P H Reggio; F Guarnieri
Journal:  J Pept Res       Date:  2002-12

2.  Chemokine receptor homo- or heterodimerization activates distinct signaling pathways.

Authors:  M Mellado; J M Rodríguez-Frade; A J Vila-Coro; S Fernández; A Martín de Ana; D R Jones; J L Torán; C Martínez-A
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

3.  Structural models for dimerization of G-protein coupled receptors: the opioid receptor homodimers.

Authors:  Marta Filizola; Harel Weinstein
Journal:  Biopolymers       Date:  2002       Impact factor: 2.505

4.  Prediction of heterodimerization interfaces of G-protein coupled receptors with a new subtractive correlated mutation method.

Authors:  Marta Filizola; Osvaldo Olmea; Harel Weinstein
Journal:  Protein Eng       Date:  2002-11

5.  Atomic-force microscopy: Rhodopsin dimers in native disc membranes.

Authors:  Dimitrios Fotiadis; Yan Liang; Slawomir Filipek; David A Saperstein; Andreas Engel; Krzysztof Palczewski
Journal:  Nature       Date:  2003-01-09       Impact factor: 49.962

6.  The fourth transmembrane segment forms the interface of the dopamine D2 receptor homodimer.

Authors:  Wen Guo; Lei Shi; Jonathan A Javitch
Journal:  J Biol Chem       Date:  2002-12-19       Impact factor: 5.157

7.  Beta2 adrenergic receptor activation. Modulation of the proline kink in transmembrane 6 by a rotamer toggle switch.

Authors:  Lei Shi; George Liapakis; Rui Xu; Frank Guarnieri; Juan A Ballesteros; Jonathan A Javitch
Journal:  J Biol Chem       Date:  2002-08-06       Impact factor: 5.157

8.  Ligand-dependent inhibition of oligomerization at the human thyrotropin receptor.

Authors:  Rauf Latif; Peter Graves; Terry F Davies
Journal:  J Biol Chem       Date:  2002-09-09       Impact factor: 5.157

9.  Use of an in situ disulfide cross-linking strategy to map proximities between amino acid residues in transmembrane domains I and VII of the M3 muscarinic acetylcholine receptor.

Authors:  Fadi F Hamdan; Stuart D C Ward; Nasir A Siddiqui; Lanh M Bloodworth; Jürgen Wess
Journal:  Biochemistry       Date:  2002-06-18       Impact factor: 3.162

10.  Heterodimerization of alpha 2A- and beta 1-adrenergic receptors.

Authors:  Jianguo Xu; Junqi He; Amanda M Castleberry; Srividya Balasubramanian; Anthony G Lau; Randy A Hall
Journal:  J Biol Chem       Date:  2003-01-15       Impact factor: 5.157

View more
  21 in total

1.  Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists.

Authors:  Beili Wu; Ellen Y T Chien; Clifford D Mol; Gustavo Fenalti; Wei Liu; Vsevolod Katritch; Ruben Abagyan; Alexei Brooun; Peter Wells; F Christopher Bi; Damon J Hamel; Peter Kuhn; Tracy M Handel; Vadim Cherezov; Raymond C Stevens
Journal:  Science       Date:  2010-10-07       Impact factor: 47.728

2.  Computational molecular biology approaches to ligand-target interactions.

Authors:  Paola Lupieri; Chuong Ha Hung Nguyen; Zhaleh Ghaemi Bafghi; Alejandro Giorgetti; Paolo Carloni
Journal:  HFSP J       Date:  2009-03-10

3.  Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the protean effects of "selective" antagonists.

Authors:  Denis Sohy; Hideaki Yano; Patricia de Nadai; Eneko Urizar; Aude Guillabert; Jonathan A Javitch; Marc Parmentier; Jean-Yves Springael
Journal:  J Biol Chem       Date:  2009-09-15       Impact factor: 5.157

4.  Methods for the Development of In Silico GPCR Models.

Authors:  Paula Morales; Dow P Hurst; Patricia H Reggio
Journal:  Methods Enzymol       Date:  2017-07-14       Impact factor: 1.600

5.  Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis.

Authors:  María Gómez-Cañas; Gemma Navarro; Paula Morales; Dow P Hurst; Francisco J Carrillo-Salinas; Laura Lagartera; Ruth Pazos; Pilar Goya; Patricia H Reggio; Carmen Guaza; Rafael Franco; Javier Fernández-Ruiz; Nadine Jagerovic
Journal:  J Med Chem       Date:  2016-07-06       Impact factor: 7.446

6.  A lipid pathway for ligand binding is necessary for a cannabinoid G protein-coupled receptor.

Authors:  Dow P Hurst; Alan Grossfield; Diane L Lynch; Scott Feller; Tod D Romo; Klaus Gawrisch; Michael C Pitman; Patricia H Reggio
Journal:  J Biol Chem       Date:  2010-03-10       Impact factor: 5.157

7.  Analysis of the activation mechanism of the guinea-pig Histamine H1-receptor.

Authors:  Andrea Strasser; Hans-Joachim Wittmann
Journal:  J Comput Aided Mol Des       Date:  2007-08-22       Impact factor: 3.686

8.  Difference and Influence of Inactive and Active States of Cannabinoid Receptor Subtype CB2: From Conformation to Drug Discovery.

Authors:  Jianping Hu; Zhiwei Feng; Shifan Ma; Yu Zhang; Qin Tong; Mohammed Hamed Alqarni; Xiaojun Gou; Xiang-Qun Xie
Journal:  J Chem Inf Model       Date:  2016-05-26       Impact factor: 4.956

9.  Structural biology of human cannabinoid receptor-2 helix 6 in membrane-mimetic environments.

Authors:  Elvis K Tiburu; Sergiy Tyukhtenko; Lalit Deshmukh; Olga Vinogradova; David R Janero; Alexandros Makriyannis
Journal:  Biochem Biophys Res Commun       Date:  2009-05-03       Impact factor: 3.575

10.  Advances in the Development and Application of Computational Methodologies for Structural Modeling of G-Protein Coupled Receptors.

Authors:  Juan Carlos Mobarec; Marta Filizola
Journal:  Expert Opin Drug Discov       Date:  2008-03       Impact factor: 6.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.